A pooled analysis of second primary pancreatic cancer

American Journal of Epidemiology

Volumn 163, Issue 6, 2006, Pages 502-511

  Shen, Min ^a,b   Boffetta, Paolo ^a   Olsen, Jørgen H ^c   Andersen, Aage ^d   Hemminki, Kari ^e,f   Pukkala, Eero ^g   Tracey, Elizabeth ^h   Brewster, David H ⁱ   McBride, Mary L ^j   Pompe Kirn, Vera ^k   Kliewer, Erich V ^l   Tonita, Jon M ^m   Chia, Kee Seng ⁿ   Martos, Carmen ^o   Jonasson, Jon G ^p   Colin, Didier ^a   Scélo, Ghislaine ^a   Brennan, Paul ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d INSTITUTE OF CANCER RESEARCH   (Norway)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f KAROLINSKA INSTITUTE   (Sweden)

^g FINNISH CANCER REGISTRY   (Finland)

^h CANCER INSTITUTE NSW   (Australia)

ⁱ Scottish Cancer Registry   (United Kingdom)

^j BRITISH COLUMBIA CANCER AGENCY   (Canada)

^k INSTITUTE OF ONCOLOGY   (Slovenia)

^l UNIVERSITY OF MANITOBA   (Canada)

^m SASKATCHEWAN CANCER AGENCY   (Canada)

ⁿ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^o Cancer Registry of Zaragoza   (Spain)

^p UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

Neoplasms, second primary; Pancreatic neoplasms; Risk factors

Indexed keywords

CANCER; DISEASE PREVALENCE; RISK FACTOR;

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CARCINOGENESIS; COLON CANCER; DISEASE ASSOCIATION; EYE CANCER; FEMALE; FOLLOW UP; GALLBLADDER CANCER; GYNECOLOGIC CANCER; HEREDITY; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; PLACENTA DISORDER; RISK FACTOR; SECOND CANCER; SMOKING; STOMACH CANCER; TESTIS CANCER; TOBACCO; UTERINE CERVIX CANCER; UTERUS CANCER;

AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PANCREATIC NEOPLASMS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS; WORLD HEALTH;

NICOTIANA TABACUM;

EID: 33644901031     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj073     Document Type: Article

References (45)

1. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. Version 1.0. Lyon, France: IARC Press, 2001. (IARC CancerBase no. 5).
2. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol VIII. Lyon, France: International Agency for Research on Cancer, 2002. (IARC scientific publication no. 155).
3. Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni JJ, eds. Cancer epidemiology and prevention. New York, NY: Oxford University Press, 1996.
4. Parkin DM, Pisani P, Lopez AD, et al. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994;59:494-504.
5. Ojajarvi IA, Partanen TJ, Ahlbom A, et al. Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med 2000;57:316-24.
6. Boice JD Jr, Storm HH, Curtis RE, et al. Introduction to the study of multiple primary cancers. Natl Cancer Inst Monogr 1985;68:3-9.
7. World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Geneva, Switzerland: World Health Organization, 1979.
8. Jensen OM, Storm HH. Cancer registration: principles and methods. Reporting of results. Lyon, France: International Agency for Research on Cancer, 1991. (IARC scientific publication no. 95).
9. Schoenberg BS, Myers MH. Statistical methods for studying multiple primary malignant neoplasms. Cancer 1977;40:1892-8.
10. Breslow NE, Day NE, eds. Statistical methods in cancer research. Vol II. The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987. (IARC scientific publication no. 82).
11. Hoar SK, Wilson J, Blot WJ, et al. Second cancer following cancer of the digestive system in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:49-82.
12. Lynge E, Jensen OM, Carstensen B. Second cancer following cancer of the digestive system in Denmark, 1943-80. Natl Cancer Inst Monogr 1985;68:277-308.
13. Neugut AI, Ahsan H, Robinson E. Pancreas cancer as a second primary malignancy. A population-based study. Cancer 1995;76:589-92.
14. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 2003;103:525-30.
15. Hemminki K, Aaltonen L, Li X. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma. Cancer 2003;97:2432-9.
16. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 2000;74:357-64.
17. Ji BT, Hatch MC, Chow WH, et al. Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer 1996;66:432-7.
18. Kvale G, Heuch I, Nilssen S. Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women. Int J Epidemiol 1994;23:691-9.
19. Bourhis J, Lacaine F, Augusti M, et al. Protective effect of oestrogen in pancreatic cancer. (Letter). Lancet 1987;2:977.
20. Fyssas I, Syrigos KN, Konstandoulakis MM, et al. Sex hormone levels in the serum of patients with pancreatic adenocarcinoma. Horm Metab Res 1997;29:115-18.
21. Kreiger N, Lacroix J, Sloan M. Hormonal factors and pancreatic cancer in women. Ann Epidemiol 2001;11:563-7.
22. Skinner HG, Michaud DS, Colditz GA, et al. Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomarkers Prev 2003;12:433-8.
23. Robinson EK, Grau AM, Evans DB, et al. Cell cycle regulation of human pancreatic cancer by tamoxifen. Ann Surg Oncol 1998;5:342-9.
24. Tomao S, Romiti A, Massidda B, et al. A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer. Anticancer Res 2002;22:2361-4.
25. Andren-Sandberg A, Hoem D, Backman PL. Other risk factors for pancreatic cancer: hormonal aspects. Ann Oncol 1999;10(suppl 4):131-5.
26. Hilgers W, Kern SE. Molecular genetic basis of pancreatic adenocarcinoma. Genes Chromosomes Cancer 1999;26:1-12.
27. Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998;90:1039-71.
28. Hemminki K, Scelo G, Boffetta P, et al. Second primary malignancies in patients with male breast cancer. Br J Cancer 2005;92:1288-92.
29. Hiyama T, Hanai A, Fujimoto I. Second primary cancer after diagnosis of stomach cancer in Osaka, Japan. Jpn J Cancer Res 1991;82:762-70.
30. Travis LB, Curtis RE, Boice JD Jr, et al. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res 1996;56:1564-70.
31. Kleinerman RA, Boice JD Jr, Storm HH, et al. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer 1995;76:442-52.
32. Travis LB, Curtis RE, Storm H, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997;89:1429-39.
33. Moller H, Mellemgaard A, Jacobsen GK, et al. Incidence of second primary cancer following testicular cancer. Eur J Cancer 1993;29A:672-6.
34. Boice JD Jr, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985;74:955-75.
35. Lundell M, Holm LE. Risk of solid tumors after irradiation in infancy. Acta Oncol 1995;34:727-34.
36. Nyberg U, Nilsson B, Travis LB, et al. Cancer incidence among Swedish patients exposed to radioactive thorotrast: a forty-year follow-up survey. Radiat Res 2002;157:419-25.
37. Lambert C, Benk V, Freeman CR. Pancreatic cancer as a second tumour following treatment of Hodgkin's disease. Br J Radiol 1998;71:229-32.
38. Chow WH, Johansen C, Gridley G, et al. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer 1999;79:640-4.
39. Cuzick J, Babiker AG. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer 1989;43:415-21.
40. Lin Y, Tamakoshi A, Kawamura T, et al. Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk. Int J Cancer 2002;99:742-6.
41. Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004;108:433-42.
42. Lutz JM, Cree IA, Foss AJ. Risk factors for intraocular melanoma and occupational exposure. Br J Ophthalmol 1999;83:1190-3.
43. Nagahama H, Okada S, Okusaka T, et al. Clinicopathological features in misdiagnosed pancreatic carcinoma. Hepatogastroenterology 1999;46:2983-5.
44. Nieman JL, Holmes FF. Accuracy of diagnosis of pancreatic cancer decreases with increasing age. J Am Geriatr Soc 1989;37:97-100.
45. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in the incidence of cervical cancer. I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998;75:536-45.